Coya Therapeutics Inc.
COYA | NASDAQ
$5.22
+$0.27 (+5.45%)
Sep 22, 2026, 12:39 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -4.57 | -5.85 | -9.38 | -3.85 | -6.18 | -10.88 |
PEG Ratio | -0.15 | -0.24 | 0.26 | -0.06 | -0.08 | n/a |
PS Ratio | 12.21 | 24.57 | 12.55 | n/a | n/a | n/a |
PB Ratio | 2.26 | 2.21 | 2.11 | -5.62 | 8.28 | 1.43 |
P/FCF Ratio | -9.04 | -8.49 | -6.73 | -6.51 | -7.47 | -30.25 |
P/OCF Ratio | -9.04 | -8.49 | -6.73 | -6.51 | -7.73 | -30.25 |
OCF/S Ratio | -135.16 | -289.49 | -186.41 | n/a | n/a | n/a |
Debt / Equity Ratio | n/a | n/a | n/a | -1.54 | n/a | n/a |
Quick Ratio | 8.50 | 11.59 | 8.15 | 1.88 | 3.99 | 19.57 |
Current Ratio | 8.50 | 11.59 | 8.15 | 1.88 | 3.99 | 19.57 |
Asset Turnover | 0.16 | 0.08 | 0.15 | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | -26.74 |
Return on Equity | -49.33% | -37.60% | -22.42% | 145.88% | -134.25% | -13.25% |
Return on Assets | -42.49% | -33.56% | -19.36% | -145.85% | -102.08% | -12.57% |
Return on Invested Capital | -45.98% | -40.60% | -21.83% | -214.61% | -133.66% | -12.55% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 99.66% | -233.86% | 8.34% | n/a | n/a | n/a |
Net Profit Margin | -267.14% | -418.70% | -133.08% | n/a | n/a | n/a |
Pretax Profit Margin | -267.10% | -438.96% | -121.02% | n/a | n/a | n/a |
Operating Profit Margin | -255.05% | -485.35% | -131.67% | n/a | n/a | n/a |
FCF Margin | -135.16% | -289.49% | -186.41% | n/a | n/a | n/a |
EBITDA Margin | -266.75% | -483.88% | -122.17% | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove COYA